CD4 and COVID-19: Taken together, these data indicate individuals who recovered from COVID‐19 retain CD4 T cells capable of responding to SARS‐CoV‐2 peptides at least 9 months after recovery towards both the spike and nucleocapsid of SARS‐CoV‐2.